Although misinformation accounts for just 2% of the overall 340B conversations taking place online, “conspiratorial narratives” driven by conservative influencers—and [...] …
Category: Research/Reports
340B contract pharmacy access bills could cost states millions and employer health plans more, according to a new study funded [...] …
A recent study suggested that 340B providers prescribe more drugs for treating breast cancer, but do not have any significant [...] …
Participation in the 340B program did not increase the number of vulnerable patients beginning targeted care for prostate cancer, a [...] …
Minnesota providers, namely the state’s largest 340B hospitals, generated hundreds of millions of dollars in collective net revenue from the [...] …
The 340B program is increasing healthcare costs for employers and driving hospital consolidation, argued panelists at a recent healthcare purchaser [...] …
Federally qualified health centers (FQHCs) appear to use their 340B program savings to enhance safety-net care, according to a new [...] …
The 340B program has outgrown patient demands and requires additional restrictions and oversight, according to a new report from a [...] …
The 340B program’s growth in recent decades has helped it attract a growing number of corporate and private equity investments, [...] …
More transparency surrounding 340B hospital operations is needed to ensure drug discount savings are being used to improve patient care, [...] …